Activating Connexin43 gap junctions primes adipose tissue for therapeutic intervention

Khaodhiar, 1999, Obesity and its comorbid conditions, Clin Cornerstone, 2, 17, 10.1016/S1098-3597(99)90002-9 White, 2014, A brief history of the development of diabetes medications, Diabetes Spectr, 27, 82, 10.2337/diaspect.27.2.82 Gimeno, 2014, FGF21-based pharmacotherapy—potential utility for metabolic disorders, Trends Endocrinol Metabol, 25, 303, 10.1016/j.tem.2014.03.001 Moller, 2012, Metabolic disease drug discovery—"hitting the target" is easier said than done, Cell Metabol, 15, 19, 10.1016/j.cmet.2011.10.012 Crewe, 2017, The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis, J Clin Invest, 127, 74, 10.1172/JCI88883 Kusminski, 2016, Targeting adipose tissue in the treatment of obesity-associated diabetes, Nat Rev Drug Discov, 15, 639, 10.1038/nrd.2016.75 Petrovic, 2010, J Biol Chem, 285, 7153, 10.1074/jbc.M109.053942 Wu, 2012, Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human, Cell, 150, 366, 10.1016/j.cell.2012.05.016 Shinoda, 2015, Genetic and functional characterization of clonally derived adult human brown adipocytes, Nat Med, 21, 389, 10.1038/nm.3819 Rogers, 2012, Aging leads to a programmed loss of brown adipocytes in murine subcutaneous white adipose tissue, Aging Cell, 11, 1074, 10.1111/acel.12010 Hanssen, 2015, Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus, Nat Med, 21, 863, 10.1038/nm.3891 Yoneshiro, 2011, Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans, Obesity, 19, 1755, 10.1038/oby.2011.125 Frayn, 2014, Regulation of human subcutaneous adipose tissue blood flow, Int J Obes, 38, 1019, 10.1038/ijo.2013.200 Baskin, 2018, Regulation of human adipose tissue activation, gallbladder size, and bile acid metabolism by a β3-adrenergic receptor agonist, Diabetes, 67, 2113, 10.2337/db18-0462 Cypess, 2015, Activation of human brown adipose tissue by a β3-adrenergic receptor agonist, Cell Metabol, 21, 33, 10.1016/j.cmet.2014.12.009 Cawthorne, 1992, BRL 35135, a potent and selective atypical β-adrenoceptor agonist, Am J Clin Nutr, 55, 10.1093/ajcn/55.1.252s Weyer, 1998, Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective β3-adrenoceptor agonist in humans, Diabetes, 47, 1555, 10.2337/diabetes.47.10.1555 Larsen, 2002, Effect of a 28-d treatment with L-796568, a novel β3-adrenergic receptor agonist, on energy expenditure and body composition in obese men, Am J Clin Nutr, 76, 780, 10.1093/ajcn/76.4.780 Redman, 2007, Lack of an effect of a novel β3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study, J Clin Endocrinol Metab, 92, 527, 10.1210/jc.2006-1740 Kharitonenkov, 2005, FGF-21 as a novel metabolic regulator, J Clin Invest, 115, 1627, 10.1172/JCI23606 Fisher, 2012, FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis, Genes Dev, 26, 271, 10.1101/gad.177857.111 Gaich, 2013, The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes, Cell Metabol, 18, 333, 10.1016/j.cmet.2013.08.005 Talukdar, 2016, A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects, Cell Metabol, 23, 427, 10.1016/j.cmet.2016.02.001 Zhu, 2016, Connexin 43 mediates white adipose tissue beiging by facilitating the propagation of sympathetic neuronal signals, Cell Metabol, 24, 420, 10.1016/j.cmet.2016.08.005 Zhu, 2013, Cardiac PI3K–Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation, Mol Endocrinol, 27, 172, 10.1210/me.2012-1210 Zhu, 2017, Hepatic GALE regulates whole-body glucose homeostasis by modulating Tff3 expression, Diabetes, 66, 2789, 10.2337/db17-0323 Wang, 2012, PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update, Nucleic Acids Res, 40, D1144, 10.1093/nar/gkr1013 Zhu, 2021, Adipose tissue hyaluronan production improves systemic glucose homeostasis and primes adipocytes for CL 316,243-stimulated lipolysis, Nat Commun, 12, 4829, 10.1038/s41467-021-25025-4 Zhu, 2013, Mechanistic target of rapamycin (Mtor) is essential for murine embryonic heart development and growth, PLoS One, 8, e54221, 10.1371/journal.pone.0054221 Shao, 2016, Zfp423 maintains white adipocyte identity through suppression of the beige cell thermogenic gene program, Cell Metabol, 23, 1167, 10.1016/j.cmet.2016.04.023 Burke, 2014, Adipocytes in both brown and white adipose tissue of adult mice are functionally connected via gap junctions: implications for Chagas disease, Microb Infect, 16, 893, 10.1016/j.micinf.2014.08.006 So, 2016, Fibroblast growth factor 21 as an emerging therapeutic target for type 2 diabetes mellitus, Med Res Rev, 36, 672, 10.1002/med.21390 Lewis, 2017, Reduced adiposity attenuates FGF21 mediated metabolic improvements in the Siberian hamster, Sci Rep, 7, 4238, 10.1038/s41598-017-03607-x Veniant, 2012, FGF21 promotes metabolic homeostasis via white adipose and leptin in mice, PLoS One, 7, e40164, 10.1371/journal.pone.0040164 Schulz, 2015, Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection, Pharmacol Ther, 153, 90, 10.1016/j.pharmthera.2015.06.005 Sun, 2013, Fibrosis and adipose tissue dysfunction, Cell Metabol, 18, 470, 10.1016/j.cmet.2013.06.016 Chau, 2010, Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway, Proc Natl Acad Sci U S A, 107, 12553, 10.1073/pnas.1006962107 Holland, 2013, An FGF21–adiponectin–ceramide axis controls energy expenditure and insulin action in mice, Cell Metabol, 17, 790, 10.1016/j.cmet.2013.03.019 Lin, 2013, Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice, Cell Metabol, 17, 779, 10.1016/j.cmet.2013.04.005 Owen, 2014, FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss, Cell Metabol, 20, 670, 10.1016/j.cmet.2014.07.012 Lan, 2017, FGF19, FGF21, and an FGFR1/β-Klotho-activating antibody act on the nervous system to regulate body weight and glycemia, Cell Metabol, 26, 10.1016/j.cmet.2017.09.005 BonDurant, 2017, FGF21 regulates metabolism through adipose-dependent and -independent mechanisms, Cell Metabol, 25, 935, 10.1016/j.cmet.2017.03.005 Keipert, 2020, Endogenous FGF21-signaling controls paradoxical obesity resistance of UCP1-deficient mice, Nat Commun, 11, 624, 10.1038/s41467-019-14069-2 Samms, 2016, Overexpression of β-Klotho in adipose tissue sensitizes male mice to endogenous FGF21 and provides protection from diet-induced obesity, Endocrinology, 157, 1467, 10.1210/en.2015-1722